Silence Therapeutics (SLN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SLN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period SLN - Silence Therapeutics PLC ADR Price vs Fair Value - MorningstarJuly 22, 2025 | morningstar.comMOwning 39% shares,institutional owners seem interested in Silence Therapeutics plc (NASDAQ:SLN),July 9, 2025 | finance.yahoo.comOne Silence Therapeutics Insider Raised Stake By 15% In Previous YearJune 12, 2025 | finance.yahoo.comSilence Therapeutics plc: Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 8, 2025 | finanznachrichten.deSilence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 8, 2025 | finance.yahoo.com20 Takeover Rumors Hedge Funds Are BuyingApril 23, 2025 | insidermonkey.comSilence Therapeutics plc (SLN): Among Takeover Rumors Hedge Funds Are BuyingApril 23, 2025 | msn.comSilence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Kura Oncology (KURA) and Silence Therapeutics (SLN)February 28, 2025 | markets.businessinsider.comH.C. WAINWRIGHT MAINTAINS $75 TARGET ON SILENCE THERAPEUTICS STOCKFebruary 3, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: Crispr Therapeutics AG (CRSP), Silence Therapeutics (SLN)December 10, 2024 | markets.businessinsider.comPromising Prospects for Silence Therapeutics: Buy Rating Justified by Positive Phase 1 Data and Safety ProfileDecember 10, 2024 | markets.businessinsider.comSilence Therapeutics: Rising Assets Amid Growing LossesNovember 15, 2024 | markets.businessinsider.comStrong Financial Position and Promising Clinical Data Support Buy Rating for Silence TherapeuticsNovember 15, 2024 | markets.businessinsider.comSilence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNovember 14, 2024 | finanznachrichten.deWe're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash WiselyOctober 28, 2024 | finance.yahoo.comSilence Therapeutics files automatic ordinary shares offeringOctober 23, 2024 | markets.businessinsider.comSilence Therapeutics plc (SLNCF)October 19, 2024 | finance.yahoo.comSilence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical AdvancementsAugust 30, 2024 | markets.businessinsider.comSilence Therapeutics plc (NASDAQ:SLN) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 18, 2024 | finance.yahoo.comSilence Therapeutics Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comSilence Therapeutics (NASDAQ:SLN) Is In A Good Position To Deliver On Growth PlansMay 21, 2024 | finance.yahoo.comBuy Rating on Silence Therapeutics: Positive Phase 2 Data and Potential for Blockbuster RevenuesMay 17, 2024 | markets.businessinsider.comPause For Effect: Utilize Strategic SilenceMay 2, 2024 | forbes.comNissan to sell tiny Silence Nanocar – and it could come to the UKApril 30, 2024 | msn.comSheryl Sandberg Says ‘Screams Before Silence’ Is the Most Important Work She’s Ever Done: ‘Women’s Bodies Need to Be Protected’ | VideoApril 29, 2024 | yahoo.comBeyond The Numbers: 7 Analysts Discuss Silence Therapeutics StockApril 22, 2024 | markets.businessinsider.comSilence Therapeutics Plc American Depository Share (SLN)April 13, 2024 | nasdaq.com‘Quiet on Set’ to Launch Fifth Episode ‘Breaking the Silence’ With New Drake Bell Interview and MoreMarch 28, 2024 | msn.comSilence Therapeutics plc: Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business HighlightsMarch 13, 2024 | finanznachrichten.deSilence Therapeutics gains on mid-stage win for lead assetMarch 13, 2024 | msn.comSilence Therapeutics Jumps on Clinical TrialsFebruary 23, 2024 | msn.comBroker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging HigherFebruary 7, 2024 | finance.yahoo.comIs Silence Golden for This Small-Cap Biotech Stock?January 31, 2024 | realmoney.thestreet.comSilence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comAll You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong BuyJanuary 11, 2024 | msn.comSilence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's WhyJanuary 5, 2024 | finance.yahoo.comThis Silence Therapeutics Insider Increased Their Holding In The Last YearDecember 24, 2023 | finance.yahoo.comHere's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep goingDecember 15, 2023 | finance.yahoo.comDoes Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?December 6, 2023 | finance.yahoo.comSilence Therapeutics PLC ADR SLNNovember 21, 2023 | morningstar.comMSilence Therapeutics: Bullish Outlook on SLN360 and Future Potential Despite Thalassemia Program DiscontinuationNovember 16, 2023 | markets.businessinsider.comIs This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease CandidateNovember 1, 2023 | markets.businessinsider.comSilence Therapeutics ADRs Rise 22% After Positive Trial ResultsNovember 1, 2023 | marketwatch.comEuropean Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday TradingOctober 27, 2023 | msn.comAT&T Unveils “Sound of Silence” Ad to Tout 5G Football Helmet PartnershipOctober 13, 2023 | msn.comSilence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines ConferenceSeptember 26, 2023 | finance.yahoo.comWhere Silence Therapeutics Stands With AnalystsAugust 17, 2023 | markets.businessinsider.comSilence Therapeutics Plc (NASDAQ: SLN)June 25, 2023 | fool.comThe Latest Analyst Ratings for Silence TherapeuticsMay 11, 2023 | markets.businessinsider.com Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address SLN Media Mentions By Week SLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼0.000.50▲Average Medical News Sentiment SLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼00▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GRI News OGN News BMY News GPH News IGC News AURA News ARTL News PHAR News KOD News MRK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SLN) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLN Stock Alerts